Literature DB >> 12574275

Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen.

Emmanuel Roilides1, Evangelia Farmaki, Joanna Evdoridou, Andrea Francesconi, Miki Kasai, Joanna Filioti, Maria Tsivitanidou, Danai Sofianou, George Kremenopoulos, Thomas J Walsh.   

Abstract

From June to July 1998, two episodes of Candida tropicalis fungemia occurred in the Aristotle University neonatal intensive care unit (ICU). To investigate this uncommon event, a prospective study of fungal colonization and infection was conducted. From December 1998 to December 1999, surveillance cultures of the oral cavities and perinea of the 593 of the 781 neonates admitted to the neonatal ICU who were expected to stay for >7 days were performed. Potential environmental reservoirs and possible risk factors for acquisition of C. tropicalis were searched for. Molecular epidemiologic studies by two methods of restriction fragment length polymorphism analysis and two methods of random amplified polymorphic DNA analysis were performed. Seventy-two neonates were colonized by yeasts (12.1%), of which 30 were colonized by Candida albicans, 17 were colonized by C. tropicalis, and 5 were colonized by Candida parapsilosis. From December 1998 to December 1999, 10 cases of fungemia occurred; 6 were due to C. parapsilosis, 2 were due to C. tropicalis, 1 was due to Candida glabrata, and 1 was due to Trichosporon asahii (12.8/1,000 admissions). Fungemia occurred more frequently in colonized than in noncolonized neonates (P < 0.0001). Genetic analysis of 11 colonization isolates and the two late blood isolates of C. tropicalis demonstrated two genotypes. One blood isolate and nine colonization isolates belonged to a single type. The fungemia/colonization ratio of C. parapsilosis (3/5) was greater than that of C. tropicalis (2/17, P = 0.05), other non-C. albicans Candida spp. (1/11, P = 0.02), or C. albicans (0/27, P = 0.05). Extensive environmental cultures revealed no common source of C. tropicalis or C. parapsilosis. There was neither prophylactic use of azoles nor other risk factors found for acquisition of C. tropicalis except for total parenteral nutrition. A substantial risk of colonization by non-C. albicans Candida spp. in the neonatal ICU may lead to a preponderance of C. tropicalis as a significant cause of neonatal fungemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574275      PMCID: PMC149715          DOI: 10.1128/JCM.41.2.735-741.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  High rate of non-albicans candidemia in Brazilian tertiary care hospitals.

Authors:  A L Colombo; M Nucci; R Salomão; M L Branchini; R Richtmann; A Derossi; S B Wey
Journal:  Diagn Microbiol Infect Dis       Date:  1999-08       Impact factor: 2.803

2.  Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains.

Authors:  C Girmenia; P Martino; F De Bernardis; G Gentile; M Boccanera; M Monaco; G Antonucci; A Cassone
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

3.  Nonperinatal nosocomial transmission of Candida albicans in a neonatal intensive care unit: prospective study.

Authors:  S E Reef; B A Lasker; D S Butcher; M M McNeil; R Pruitt; H Keyserling; W R Jarvis
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

4.  Cluster of Candida parapsilosis primary bloodstream infection in a neonatal intensive care unit.

Authors:  C L da Silva; R M dos Santos; A L Colombo
Journal:  Braz J Infect Dis       Date:  2001-02       Impact factor: 1.949

5.  Invasive candidosis in pediatric patients.

Authors:  Emmanuel Roilides; Isaac Kadiltsoglou; Dimitrios Zahides; Evangelia Bibashi
Journal:  Clin Microbiol Infect       Date:  1997-04       Impact factor: 8.067

Review 6.  Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.

Authors:  V Krcmery; A J Barnes
Journal:  J Hosp Infect       Date:  2002-04       Impact factor: 3.926

7.  Candida parapsilosis bloodstream infections in neonatal intensive care unit patients: epidemiologic and laboratory confirmation of a common source outbreak.

Authors:  S F Welbel; M M McNeil; R J Kuykendall; T J Lott; A Pramanik; R Silberman; A D Oberle; L A Bland; S Aguero; M Arduino; S Crow; W R Jarvis
Journal:  Pediatr Infect Dis J       Date:  1996-11       Impact factor: 2.129

8.  Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients.

Authors:  D Sullivan; D Bennett; M Henman; P Harwood; S Flint; F Mulcahy; D Shanley; D Coleman
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

9.  Amphotericin B-resistant yeast infection in severely immunocompromised patients.

Authors:  W G Powderly; G S Kobayashi; G P Herzig; G Medoff
Journal:  Am J Med       Date:  1988-05       Impact factor: 4.965

10.  Candida tropicalis: a major pathogen in immunocompromised patients.

Authors:  J R Wingard; W G Merz; R Saral
Journal:  Ann Intern Med       Date:  1979-10       Impact factor: 25.391

View more
  9 in total

1.  Use of quantitative real-time PCR to study the kinetics of extracellular DNA released from Candida albicans, with implications for diagnosis of invasive Candidiasis.

Authors:  Miki Kasai; Andrea Francesconi; Ruta Petraitiene; Vidmantas Petraitis; Amy M Kelaher; Hee-Sup Kim; Joseph Meletiadis; Tin Sein; John Bacher; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

2.  Epidemiology and microbiology of nosocomial pediatric candidemia at a northern Indian tertiary care hospital.

Authors:  Avijit Kumar Awasthi; Amita Jain; Shally Awasthi; Ankur Ambast; Kamlesh Singh; Vijendra Mishra
Journal:  Mycopathologia       Date:  2011-05-01       Impact factor: 2.574

3.  Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates.

Authors:  E Roilides; E Farmaki; J Evdoridou; J Dotis; E Hatziioannidis; M Tsivitanidou; E Bibashi; I Filioti; D Sofianou; C Gil-Lamaignere; F-M Mueller; G Kremenopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10       Impact factor: 3.267

Review 4.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

5.  Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions.

Authors:  Shiang Ning Leaw; Hsien Chang Chang; Hsiao Fang Sun; Richard Barton; Jean-Philippe Bouchara; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

6.  Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome.

Authors:  Marie-Elisabeth Bougnoux; Guillaume Kac; Philippe Aegerter; Christophe d'Enfert; Jean-Yves Fagon
Journal:  Intensive Care Med       Date:  2007-10-02       Impact factor: 17.440

7.  Epidemiology and molecular typing of Candida isolates from burn patients.

Authors:  Nivedita Gupta; Absarul Haque; Ali Abdul Lattif; R P Narayan; Gauranga Mukhopadhyay; Rajendra Prasad
Journal:  Mycopathologia       Date:  2004-11       Impact factor: 3.785

8.  Emergence of non-albicans Candida species in neonatal candidemia.

Authors:  Deepak Juyal; Munesh Sharma; Shekhar Pal; Vyas Kumar Rathaur; Neelam Sharma
Journal:  N Am J Med Sci       Date:  2013-09

9.  Particularities of the management and the treatment in a rare sepsis with Candida tropicalis of a Collodion baby: Case report.

Authors:  Alina Mariela Murgu; Irina Geanina Crişcov; Silvia Fotea; Ginel Baciu; Anca Chiriac; Elena Tarca; Violeta Streanga
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.